149353-84-4

Usage

Uses

Used in Pharmaceutical Research:
4-(4''-Carboxyphenyl)piperidine HCl is used as a research compound for investigating its binding affinity to different receptors. This helps in understanding its potential as a treatment for certain conditions and contributes to the development of new drugs.
Used in Drug Development:
In the pharmaceutical industry, 4-(4''-Carboxyphenyl)piperidine HCl is utilized as a lead compound in drug development. Its unique structure and biological activities make it a promising candidate for the creation of new therapeutic agents.
Used in Chemical Synthesis:
4-(4''-Carboxyphenyl)piperidine HCl is employed as a building block in the synthesis of more complex organic compounds. Its versatile structure allows for the development of novel molecules with potential applications in various fields.

Upstream product

• 79-37-8 oxalyl dichloride 
• 32245-87-7 1-(4-Phenyl-piperidin-1-yl)-ethanone 
• 771-99-3 4-phenylpiperidine 

Downstream Products

• 149353-75-3 4-(1-(tert-butoxycarbonyl)piperidin-4-yl)benzoic acid 
• 1622204-19-6 6-(2-methoxyethoxy)-N-methyl-5-{[2-({[4-(piperidin-4-yl)phenyl]carbonyl}amino)pyridin-4-yl]oxy}-1H-indole-1-carboxamide 
• 1622204-21-0 (5-({2-[({4-[1-(2-hydroxyethyl)piperidin-4-yl]phenyl}carbonyl)amino]pyridin-4-yl}oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide) 

Relevant academic research and scientific papers

SALT OF MONOCYCLIC PYRIDINE DERIVATIVE AND CRYSTAL THEREOF

The present invention provides salts consisting of an organocarboxylic acid selected from the group consisting of succinic acid and maleic acid and a compound represented by formula (I) and crystals thereat which can be used as bulk materials for pharmaceuticals.

MONOCYCLIC PYRIDINE DERIVATIVE

The present invention provides a novel compound having FGFR inhibitory activity or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same. Specifically, the present invention provides a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or —CH2—; E represents a nitrogen-containing non-aromatic heterocycle; R1 represents an alkoxy group or the like; R2 represents a hydrogen atom or the like; and R3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like, with the proviso that when E represents an azetidine ring and R2 or R3 is present on a nitrogen atom on the azetidine ring, the R2 or R3 does not represent a hydrogen atom.

Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them

The invention relates to carboxylic acid derivatives of general formula wherein A to G are defined as in claim 1, the tautomers thereof, the stereoisomers thereof including the mixtures thereof and the addition salts thereof, particularly the physiologically acceptable salts with inorganic or organic acids or bases, which have valuable pharmacological properties, preferably inhibitory effects on aggregation, and to pharmaceutical compositions containing the compounds and processes for preparing them.

2-pyrrolidinones, pharmaceutical compositions containing these compounds and processes for preparing them

The invention relates to cyclic imino derivatives of general formula wherein A, B, E, X2 to X5 and Y are defined as in claim 1, the stereoisomers, tautomers, mixtures and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable pharmacological properties, preferably aggregation-inhibiting effects, pharmaceutical compositions which contain these compounds and processes for preparing them.